These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 20870003)
21. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038 [TBL] [Abstract][Full Text] [Related]
22. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062 [TBL] [Abstract][Full Text] [Related]
23. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429 [TBL] [Abstract][Full Text] [Related]
24. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma. Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363 [TBL] [Abstract][Full Text] [Related]
25. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells. Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540 [TBL] [Abstract][Full Text] [Related]
26. [The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients]. Zhang HH; Fei R; Mei MH; Liao WJ; Wang XY; Cong X; Qin LL; Ji Y; Wang SX; Wei L; Chen HS Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):266-72. PubMed ID: 17456313 [TBL] [Abstract][Full Text] [Related]
27. Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma. Fu J; Zhang Z; Zhou L; Qi Z; Xing S; Lv J; Shi J; Fu B; Liu Z; Zhang JY; Jin L; Zhao Y; Lau GK; Zhao J; Wang FS Hepatology; 2013 Jul; 58(1):139-49. PubMed ID: 22961630 [TBL] [Abstract][Full Text] [Related]
28. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488 [TBL] [Abstract][Full Text] [Related]
29. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Cai MY; Xu YF; Qiu SJ; Ju MJ; Gao Q; Li YW; Zhang BH; Zhou J; Fan J Clin Cancer Res; 2009 Jul; 15(14):4686-93. PubMed ID: 19584149 [TBL] [Abstract][Full Text] [Related]
30. Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis. Gupta S; Joshi K; Wig JD; Arora SK Acta Oncol; 2007; 46(6):792-7. PubMed ID: 17653902 [TBL] [Abstract][Full Text] [Related]
31. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes. Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857 [TBL] [Abstract][Full Text] [Related]
33. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967 [TBL] [Abstract][Full Text] [Related]
34. Prognostic Role of Immune Cells in Hepatitis B-associated Hepatocellular Carcinoma Following Surgical Resection Depends on Their Localization and Tumor Size. Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Mandeli J; Hiotis SP J Immunother; 2016 Jan; 39(1):36-44. PubMed ID: 26641260 [TBL] [Abstract][Full Text] [Related]
35. Regulatory T cells and their prognostic value in hepatopancreatobiliary tumours. Ozgur HH; Ercetin AP; Eliyatkin N; Seren A; Kupelioglu A; Ortac R; Diniz G; Aktas S Hepatogastroenterology; 2014 Oct; 61(135):1847-51. PubMed ID: 25713876 [TBL] [Abstract][Full Text] [Related]
36. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843 [TBL] [Abstract][Full Text] [Related]
37. Increased frequency and FOXP3 expression of human CD8 Zahran AM; Nafady-Hego H; Mansor SG; Abbas WA; Abdel-Malek MO; Mekky MA; Hetta HF Hum Immunol; 2019 Jul; 80(7):510-516. PubMed ID: 30904437 [TBL] [Abstract][Full Text] [Related]
38. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma. Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300 [TBL] [Abstract][Full Text] [Related]
39. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells. Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832 [TBL] [Abstract][Full Text] [Related]
40. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients. Guo CL; Yang XH; Cheng W; Xu Y; Li JB; Sun YX; Bi YM; Zhang L; Wang QC Asian Pac J Cancer Prev; 2014; 15(6):2613-8. PubMed ID: 24761872 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]